Weekly Policy Update: State Legislators Introduce Bill to Extend Innovative Industries Internship Program
By: Colorado BioScience Association Date: 03/06/2020
State legislators introduced a bill this week to extend the Innovative Industries Internship Program for another five years. The program was created in 2015 to meet the critical needs of Colorado’s lo...
Learn MoreColorado BioScience Association Offers FDA Leader’s Perspective During Keynote at Medical Device Symposium
By: Colorado BioScience Association Date: 03/04/2020
Dr. Jeffrey Shuren to Join Conference Live via Video from Washington, D.C. DENVER – Colorado BioScience Association (CBSA) welcomes FDA’s Dr. Jeffrey Shuren via video conference to today’s annual Medi...
Learn MoreWeekly Policy Update: CBSA Meets with Federal Policymakers to Discuss Coverage + Payment for Breakthrough Technologies
By: Colorado BioScience Association Date: 02/28/2020
CBSA was in DC this week representing Colorado’s life sciences ecosystem as part of the AdvaMed Fly-in. It was a great opportunity to meet with the Colorado delegation offices and advocate for federal...
Learn MoreWeekly Policy Update: Health Care Stakeholders Convene to Discuss Total Cost of Care Legislation
By: Colorado BioScience Association Date: 02/21/2020
At a stakeholder meeting on Tuesday the Colorado Hospital Association walked through their draft proposal for a total cost of care model in Colorado. Based on programs already operating in Oregon and...
Learn MoreWeekly Policy Update: Drug Price Transparency and Drug Importation Bills Pass Health Committees
By: Colorado BioScience Association Date: 02/14/2020
CBSA was at the Colorado State Capitol again this week to voice our concerns about legislation focused on drug price transparency and prescription drug importation. House Bill 1160, Drug Price Transpa...
Learn MoreWeekly Policy Update: CBSA Represents Colorado’s Life Sciences Ecosystem in Senate Committee Hearings
By: Colorado BioScience Association Date: 02/07/2020
This week, CBSA weighed in on Senate Bill 10, Repeal Ban on Local Government Regulation of Plastics, to ensure life-saving medicines and medical devices are not impacted by local regulations on single...
Learn MoreDenver Business Journal Covers New Partnership to Fund Early-Stage Life Sciences Companies
By: Colorado BioScience Association Date: 02/07/2020
Colorado BioScience Association and Rockies Venture Club recently announced a new effort to fund early-stage life sciences companies in Colorado, funded by an Advanced Industries Accelerator Grant fro...
Learn MoreColorado BioScience Association Highlights Life Sciences Impact at the State Capitol OEDIT Executive Director Betsy Markey Keynotes CBSA’s Annual Day at the Capitol
By: Colorado BioScience Association Date: 02/04/2020
DENVER – Colorado BioScience Association (CBSA) brings leaders from Colorado life sciences companies and organizations to the State Capitol today, February 4, 2020, to share innovation stories with le...
Learn MoreWeekly Policy Update: CBSA Opposes Expanded Prescription Drug Importation Program
By: Colorado BioScience Association Date: 01/31/2020
Last week Senator Joann Ginal introduced Senate Bill 119, Expand Canadian Prescription Drug Import Program. The bill builds on legislation that was enacted last session, that directed the Dept. of Hea...
Learn MoreWeekly Policy Update: Drug Price Transparency Bills Introduced in the House and Senate
By: Colorado BioScience Association Date: 01/24/2020
Over the past week, state legislators have introduced two drug price transparency bills that could impact our life sciences community. The first bill (SB20-107) was introduced in the Senate by Sen. Jo...
Learn More